BML Capital Management LLC Grows Holdings in Talis Biomedical Co. (NASDAQ:TLIS)

BML Capital Management LLC lifted its holdings in Talis Biomedical Co. (NASDAQ:TLIS) by 481.9% in the third quarter, HoldingsChannel reports. The fund owned 248,702 shares of the company’s stock after buying an additional 205,959 shares during the period. Talis Biomedical makes up 0.3% of BML Capital Management LLC’s investment portfolio, making the stock its 24th biggest position. BML Capital Management LLC owned approximately 0.14% of Talis Biomedical worth $460,000 at the end of the most recent reporting period.

Talis Biomedical Stock Performance

NASDAQ:TLIS traded up $0.05 during midday trading on Tuesday, reaching $1.85. 2,400 shares of the stock traded hands, compared to its average volume of 13,487. The company has a fifty day moving average of $1.79 and a 200 day moving average of $5.73. Talis Biomedical Co. has a 12 month low of $1.37 and a 12 month high of $9.60. The stock has a market capitalization of $3.37 million, a P/E ratio of -0.06 and a beta of 1.56.

Talis Biomedical (NASDAQ:TLIS) last issued its quarterly earnings data on Monday, August 19th. The company reported ($4.86) EPS for the quarter. Talis Biomedical had a negative return on equity of 79.74% and a negative net margin of 5,784.73%.

Insider Activity at Talis Biomedical

In related news, major shareholder Braden Michael Leonard purchased 13,167 shares of the company’s stock in a transaction dated Monday, August 26th. The shares were purchased at an average price of $3.90 per share, with a total value of $51,351.30. Following the acquisition, the insider now directly owns 216,736 shares in the company, valued at $845,270.40. The trade was a 0.00 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In the last ninety days, insiders have bought 15,033 shares of company stock valued at $58,804. 46.00% of the stock is owned by insiders.

About Talis Biomedical

Talis Biomedical Corporation operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Chicago, Illinois.